Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xavier Montalban
Comparing Outcomes From Clinical Studies of Oral Disease-Modifying Therapies (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Relapsing MS: Assessing Absolute Differences Using a Number Needed to Treat Analysis
Multiple Sclerosis and Related Disorders
Medicine
Neurology
Transcription-Based Prediction of Response to IFNβ Using Supervised Computational Methods
PLoS Biology
Immunology
Molecular Biology
Genetics
Biochemistry
Microbiology
Biological Sciences
Agricultural
Neuroscience
‹
1
2
Related publications
Assessing the Comparative Outcomes From Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Nd3 - Meta-Analysis of Real-World Adherence and Persistence of Maintenance Once- Or Twice-Daily Oral Disease-Modifying Drugs (Dimethyl Fumarate, Fingolimod, and Teriflunomide) in Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd55 - A Cost-Effectiveness Analysis Using Real-World Data From the Msbase Registry: Comparing Natalizumab to Fingolimod in Patients With Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd56 - A Cost-Effectiveness Analysis Using Real-World Data From the Msbase Registry: Comparing Natalizumab to Fingolimod in Patients With Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
HDL-cholesterol Elevation Associated With Fingolimod and Dimethyl Fumarate Therapies in Multiple Sclerosis
Multiple Sclerosis Journal - Experimental, Translational and Clinical
Pnd72 - Cost-Minimization Analysis of Teriflunomide and Dimethyl Fumarate for Treatment of Relapsing-Remitting Forms of Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Comparing the Quality of Life Among Patients With Relapsing Remitting Multiple Sclerosis in Iraq Using Different Disease Modifying Therapies
Iraqi Journal of Pharmaceutical Sciences
Toxicology
Analytical Chemistry
Pharmaceutics
Pharmacology
Reporting Number Needed to Treat and Absolute Risk Reduction in Randomized Controlled Trials
JAMA - Journal of the American Medical Association
Medicine
